1IALT(The International Adjuvant Lung Cancer Trial Collaborative Group). Cisplatin-based adjuvant chemotherapy in patients with completely resected Non-small-cell lung cancer[J]. N Engl J Med, 2004,350:351-360.
2Scagliotti GV, Fossati R, Torri V, et al. Randomized study of adjuvant chemotherapy for completely resected stageⅠ , Ⅱ, or Ⅲ A Non-small-cell lung cancer [J]. J Natl Cancer Inst, 2003, 95: 1453-1461.
3Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-smallcell lung cancer[J]. N Engl J Med, 2002,346(2):92-98.
4Manegold C. Gemcitabine (Gemzar) in non-small cell lung cancer [J]. Expert Rev Anticancer Ther,2004,4(3):345-360.
5Dimopoulou I, Efstathiou E, Samakovli A, et al. A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment[J]. Ann Oncol, 2004, 15(8):1250-1255.
6Comella P, Frasci G, Carnicelli P, et al. Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients[J]. Br J Cancer, 2004, 13: [Epub ahead of print] .
7Park YH, Lee JC, Kim CH, et al. Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum [J].Jpn J Clin Oncol, 2004, 34(5):245-249.
8Laack E, Dickgreber N, Muller T, et al. German and Swiss Lung Cancer Study Group. Randomized phase Ⅲstudy of gemcitabine and vinorelbine versus gemcitabine,vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and SwissLung Cancer Study Group[J]. J Clin Oncol, 2004, 22(12):2348-2356.
9Georgoulias V, Kouroussis C, Agelidou A,et al. Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre,randomised, phase Ⅱ study[J].Br J Cancer, 2004, [Epub ahead of print].
10Oliani C, Padovani M, Manno P, et al. Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase Ⅰ -Ⅱ study[J].Anticancer Res, 2004, 24(3b):2107-2112.
